Merck & Co., Inc. 13F Portfolio

EntityCategoryQoQ AUM ChangeAUM (13F)# of HoldingsPerformance RankEquities Trend
MC
Merck & Co., Inc.
Institutional Filer 26.48%$349.4M14

Current Portfolio Holdings

Showing all 14 reported positions by value

#StockCompany NameSectorShares HeldMarket Value% of Portfolio
1MRNAModerna, Inc.Healthcare2.3M$117.3M33.56%
2PSNLPersonalis, Inc.Healthcare14.0M$89.5M25.60%
3KYMRKymera Therapeutics, Inc.Healthcare772K$64.3M18.40%
4NaNENTRADA THERAPEUTICS INC1.7M$22.0M6.28%
5EIKNEIKON THERAPEUTICS INC1.7M$17.6M5.05%
6AKTSAKTIS ONCOLOGY INC953K$17.0M4.88%
7ALECAlector, Inc.Healthcare3.5M$7.6M2.18%
8STROSutro Biopharma, Inc.Healthcare272K$6.8M1.94%
9EVAXEvaxion Biotech A/SHealthcare1.2M$4.5M1.29%
10VRDNViridian Therapeutics, Inc.Healthcare93K$1.8M0.52%
11NaNXILIO THERAPEUTICS INC106K$891K0.26%
12CARMCarisma Therapeutics, Inc.Healthcare1.5M$48K0.01%
13NEUPNeuphoria Therapeutics Inc.Healthcare10K$41K0.01%
14HURATuHURA Biosciences, Inc.Healthcare19K$35K0.01%
Showing 1 to 14 of 14 holdings
Merck & Co., Inc. 13F Portfolio Holdings & Trades (Q1 2026) | VCP Scanner